Cargando…
Characterization of a novel focal adhesion kinase inhibitor in human platelets
Focal adhesion kinase (FAK) is activated in human platelets downstream of integrins, e.g. α(IIb)β(3), and other adhesion receptors e.g. GPVI. Mice in which platelets lack FAK have been shown to exhibit extended bleeding times and their platelets have been shown to display decreased spreading on fibr...
Autores principales: | Jones, Matthew L., Shawe-Taylor, Amelia J., Williams, Christopher M., Poole, Alastair W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2812699/ https://www.ncbi.nlm.nih.gov/pubmed/19716803 http://dx.doi.org/10.1016/j.bbrc.2009.08.132 |
Ejemplares similares
-
Focal adhesion kinase inhibitors, a heavy punch to cancer
por: Wu, Yueling, et al.
Publicado: (2021) -
Focal Adhesion Kinases in Adhesion Structures and Disease
por: Eleniste, Pierre P., et al.
Publicado: (2012) -
Y‐27632, an Inhibitor of Rho‐associated Protein Kinase, Suppresses Tumor Cell Invasion via Regulation of Focal Adhesion and Focal Adhesion Kinase
por: Imamura, Fumio, et al.
Publicado: (2000) -
Focal Adhesion Kinase Inhibitor Inhibits the Oxidative Damage Induced by Central Venous Catheter via Abolishing Focal Adhesion Kinase-Protein Kinase B Pathway Activation
por: Wang, Yanru, et al.
Publicado: (2021) -
Targeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions
por: Mousson, Antoine, et al.
Publicado: (2018)